Kinnevik Ab (publ)
Kinnevik AB (publ) is a Swedish investment company headquartered in Stockholm, founded in 1936 by the Stenbeck, Klingspor, and von Horn families. It is a leading growth investor, active owner, and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US. Kinnevik focuses on investments within healthcare, software, marketplaces, and climate tech, and serves a global investor base through large cap listing on Nasdaq Stockholm. The firm employs around 60 people and supports founders building transformative companies with a long-term philosophy.
Investment Strategy
Kinnevik is a long-term, active owner investing predominantly in disruptive, technology-enabled businesses within healthcare, software, and climate sectors, with a focus on Europe and the US. The firm provides patient capital, partnering across all growth stages to back founders who aim to redefine industries and foster significant market opportunities. Kinnevik acts as an operational partner, focusing on value creation through supporting organic and inorganic growth, and maintains a disciplined approach toward sustained profitability and industry disruption.
Top Holdings
Equity Positions (1)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
R RXRX | Recursion Pharmaceuticals, Inc. | 100.00% | $68.0M | 13,434,171 | $7.36 | $5.06 | -$3.1M |